
|Articles|December 1, 2002
The American Journal of Managed Care
- December 2002
- Volume 8
- Issue 12
Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective
Author(s)Gregory de Lissovoy, PhD, Prasun Subedi, BS
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Integrated Care for Chronic Conditions: A Randomized Care Management Trial
2
What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light
3
Daratumumab Offers Hope for Delaying Progression to Active MM: Peter Voorhees, MD
4
It’s Time to Reimagine Reimbursement for CAR T-Cell Therapy
5













































